[The new antipsychotic preparation Rispolept (risperidone)].
Iakovlev
V A
VA
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001714:Bipolar Disorder / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D018967:Risperidone / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D012559:Schizophrenia / Q000188:drug therapy; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D012702:Serotonin Antagonists; D018967:Risperidone